Cargando…

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

BACKGROUND: Neoadjuvant Chemotherapy (NC) including trastuzumab induces a high rate of pathological Complete Responses (pCR) in patients with locally advanced HER2-overexpressing Breast Cancer (BC), but is penalized by a severe cardiotoxicity when combined with anthracyclines. A phase II study was d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miolo, Gianmaria, Muraro, Elena, Martorelli, Debora, Lombardi, Davide, Scalone, Simona, Spazzapan, Simon, Massarut, Samuele, Perin, Tiziana, Viel, Elda, Comaro, Elisa, Talamini, Renato, Bidoli, Ettore, Turchet, Elisa, Crivellari, Diana, Dolcetti, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302069/ https://www.ncbi.nlm.nih.gov/pubmed/25512030 http://dx.doi.org/10.1186/1471-2407-14-954

Ejemplares similares

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy
por: Muraro, E, et al.
Publicado: (2015)

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies
por: Muraro, Elena, et al.
Publicado: (2011)

KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer
por: Muraro, Elena, et al.
Publicado: (2022)

Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study
por: Veronesi, Andrea, et al.
Publicado: (2010)

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer
por: Miolo, Gianmaria, et al.
Publicado: (2016)

Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers
por: Miolo, GianMaria, et al.
Publicado: (2009)

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer
por: Muraro, Elena, et al.
Publicado: (2017)

Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies
por: Tuzi, Alessandro, et al.
Publicado: (2013)

Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders
por: Martorelli, Debora, et al.
Publicado: (2012)

Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy
por: Miolo, GianMaria, et al.
Publicado: (2006)

Familial breast cancer: characteristics and outcome of BRCA 1–2 positive and negative cases
por: Veronesi, Andrea, et al.
Publicado: (2005)

Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients
por: Corona, Giuseppe, et al.
Publicado: (2023)

Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin
por: Miolo, Gianmaria, et al.
Publicado: (2023)

Primary extragenital endometrial stromal sarcoma of the lung: first reported case and review of literature
por: Alessandrini, Lara, et al.
Publicado: (2017)

Anthracycline dose and liver dysfunction
por: Cannizzaro, R, et al.
Publicado: (1999)

Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin
por: Miolo, Gianmaria, et al.
Publicado: (2020)

Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas
por: Vignoli, Alessia, et al.
Publicado: (2023)

Breast metastasis of primary colon cancer with micrometastasis in the axillary sentinel node: A metastasis that metastasized?
por: Perin, Tiziana, et al.
Publicado: (2011)

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4(+) T Cells
por: Muraro, Elena, et al.
Publicado: (2017)

Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy
por: Cini, Giulia, et al.
Publicado: (2016)

(1)H-NMR Plasma Lipoproteins Profile Analysis Reveals Lipid Metabolism Alterations in HER2-Positive Breast Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2021)

Seven fractions to deliver partial breast irradiation: the toxicity is Low
por: Trovo, Marco, et al.
Publicado: (2017)

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients
por: Sigalotti, Luca, et al.
Publicado: (2011)

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
por: Cucciniello, Linda, et al.
Publicado: (2022)

Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
por: Muraro, Elena, et al.
Publicado: (2022)

Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy
por: Vignoli, Alessia, et al.
Publicado: (2020)

Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma
por: Mastorci, Katy, et al.
Publicado: (2016)

Radical Hemithoracic Radiotherapy Induces Systemic Metabolomics Changes That Are Associated with the Clinical Outcome of Malignant Pleural Mesothelioma Patients
por: Di Gregorio, Emanuela, et al.
Publicado: (2021)

Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling
por: Segatto, Ilenia, et al.
Publicado: (2014)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
por: Garutti, Mattia, et al.
Publicado: (2023)

Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas
por: Buonadonna, Angela, et al.
Publicado: (2023)

La synergologie: pour comprendre son interlocuteur à travers sa gestuelle
por: Turchet, Philippe
Publicado: (2000)

Musical Metaverse: vision, opportunities, and challenges
por: Turchet, Luca
Publicado: (2023)

Biological Predictors of De Novo Tumors in Solid Organ Transplanted Patients During Oncological Surveillance: Potential Role of Circulating TERT mRNA
por: Cangemi, Michela, et al.
Publicado: (2021)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

The Beneficial Role of Physical Exercise on Anthracyclines Induced Cardiotoxicity in Breast Cancer Patients
por: Tranchita, Eliana, et al.
Publicado: (2022)

Differences in Working Memory With Emotional Distraction Between Proficient and Non-proficient Bilinguals
por: Ma, Xie, et al.
Publicado: (2020)

FSH: fast spaced seed hashing exploiting adjacent hashes
por: Girotto, Samuele, et al.
Publicado: (2018)

Higher recall in metagenomic sequence classification exploiting overlapping reads
por: Girotto, Samuele, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tlk92uj9ugh33n03e0bim1e5q8